The prognosis of patients having received optimal therapy for nonvariceal upper gastrointestinal bleeding might be worse in daily practice than in randomized clinical trials. [electronic resource]
Producer: 20100428Description: 361-7 p. digitalISSN:- 1473-5687
- 2-Pyridinylmethylsulfinylbenzimidazoles -- administration & dosage
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Chi-Square Distribution
- Combined Modality Therapy
- Female
- France -- epidemiology
- Hemostasis, Endoscopic -- adverse effects
- Hospital Mortality
- Hospitals, University
- Humans
- Infusions, Intravenous
- Injections, Intravenous
- Intensive Care Units
- Logistic Models
- Male
- Middle Aged
- Odds Ratio
- Pantoprazole
- Peptic Ulcer Hemorrhage -- mortality
- Proton Pump Inhibitors -- administration & dosage
- Randomized Controlled Trials as Topic
- Recurrence
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.